Skip to main content

MoneyWorks4Me

Lupin informs about press release

06 Jun 2016 Evaluate

Lupin has informed about a Press Release dated June 06, 2016 titled ‘Lupin Receives FDA Approvals for Generic Vfend Tablets 50mg, 200mg & Vfend Oral Suspension, 40 mg/mL’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..